Chanhen(SZ:002895) Changjiang Securities·2025-08-28 10:12Investment Rating - The report maintains a "Buy" rating for the company [8]. Core Views - The company reported a significant increase in revenue and profit for the first half of 2025, achieving revenue of 3.36 billion yuan (up 35.3% year-on-year) and a net profit attributable to shareholders of 540 million yuan (up 51.5% year-on-year) [2][7]. - In Q2 2025, the company generated revenue of 1.87 billion yuan (up 29.6% year-on-year, up 25.1% quarter-on-quarter) and a net profit of 330 million yuan (up 52.5% year-on-year, up 65.3% quarter-on-quarter) [2][7]. - The company plans to distribute a cash dividend of 3.0 yuan per 10 shares (including tax) [7]. Summary by Sections Financial Performance - The company achieved a total revenue of 5.906 billion yuan for 2025E, with a projected net profit of 1.292 billion yuan [16]. - The gross profit margin for Q2 2025 was 33.1%, with a net profit margin of 18.7%, reflecting improvements in operational efficiency [11]. - The company expects net profits of 1.29 billion yuan, 1.47 billion yuan, and 1.64 billion yuan for 2025, 2026, and 2027 respectively [11]. Market Position - The company is a leading player in the domestic phosphate chemical industry, with significant phosphate rock production capacity of 3 million tons per year and additional capacity under construction of 9.3 million tons per year [11]. - The company benefits from a strong supply chain and is focused on enhancing its phosphate chemical industry chain from phosphate rock to phosphate salt products [11]. Product Performance - The company has seen notable growth in sales of its main products, including dihydrogen phosphate, industrial-grade monoammonium phosphate, and phosphoric acid, driven by increased demand and rising raw material prices [11]. - The average price changes for key products in Q2 2025 were 19.6%, 8.9%, 5.1%, and 1.4% year-on-year, indicating a positive pricing environment [11].